{"nctId":"NCT05053087","briefTitle":"A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty","startDateStruct":{"date":"2022-04-13","type":"ACTUAL"},"conditions":["Osteoarthritis, Knee"],"count":60,"armGroups":[{"label":"Ropivacaine intermittent bolus","type":"EXPERIMENTAL","interventionNames":["Drug: Ropivacaine Intermittent Bolus"]},{"label":"Ropivacaine continuous","type":"EXPERIMENTAL","interventionNames":["Drug: Ropivacaine Continuous Infusion"]},{"label":"Single shot adductor canal","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Ropivacaine Continuous Infusion","otherNames":[]},{"name":"Ropivacaine Intermittent Bolus","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥ 18 and ≤ 90 years.\n* Willing to participate in the study and competent to provide informed consent.\n* Willing to comply with protocol procedures.\n* Has an underlying diagnosis of osteoarthritis indicated for a total knee arthroplasty.\n\nExclusion Criteria:\n\n* The patient must not have taken any narcotic medications (schedule II) during the 3 months leading up to the surgery.\n* The patient must not be allergic or intolerant to a medication used in the multimodal pain pathway.\n* Revision knee arthroplasty.\n* Uncontrolled diabetes with A1C \\> 8.0%.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"89 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Post-operative Pain Levels","description":"Patient self-reported pain intensity score measured on the Visual Analogue Scale (VAS) rated from 0-10, where 0 was no pain and 10 was the worst pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.1","spread":null},{"groupId":"OG001","value":"5.1","spread":null},{"groupId":"OG002","value":"6.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Amount of Medication Administered","description":"Amount of medication administered via the patient-controlled function on the adductor catheter","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"138","spread":null},{"groupId":"OG001","value":"111","spread":null},{"groupId":"OG002","value":"144","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Narcotic Used","description":"Number of days that narcotic use was required.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"14","spread":null},{"groupId":"OG002","value":"14","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":["Catheter removed early","Catheter placed incorrectly","Fever","Knew swelling","Knee bruising"]}}}